A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

Bárbara M Schultz; Felipe Melo-González; Luisa F Duarte; Nicolás MS Gálvez; Gaspar A Pacheco; Jorge A Soto; Roslye V Berríos-Rojas; Liliana A González; Daniela Moreno-Tapia; Daniela Rivera-Pérez; Guillermo Hoppe-Elsholz; Carolina Iturriaga; Mariana Ríos; Omar P Vallejos; Marcela Urzua; Yaneisi Vázquez; María S Navarrete; Álvaro Rojas; Daniela Weiskopf; Alessandro Sette; Gang Zeng; Weining Meng; CoronaVac03CL Study Group; José V González-Aramundiz; Pablo A González; Katia Abarca; Alexis M Kalergis; Susan M Bueno

doi:10.1101/2021.11.16.21266350

A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

View ORCID ProfileBárbara M Schultz, View ORCID ProfileFelipe Melo-González, View ORCID ProfileLuisa F Duarte, View ORCID ProfileNicolás MS Gálvez, View ORCID ProfileGaspar A Pacheco, View ORCID ProfileJorge A Soto, View ORCID ProfileRoslye V Berríos-Rojas, Liliana A González, View ORCID ProfileDaniela Moreno-Tapia, View ORCID ProfileDaniela Rivera-Pérez, View ORCID ProfileGuillermo Hoppe-Elsholz, Carolina Iturriaga, Mariana Ríos, View ORCID ProfileOmar P Vallejos, Marcela Urzua, View ORCID ProfileYaneisi Vázquez, María S Navarrete, Álvaro Rojas, Daniela Weiskopf, View ORCID ProfileAlessandro Sette, Gang Zeng, Weining Meng, CoronaVac03CL Study Group, View ORCID ProfileJosé V González-Aramundiz, View ORCID ProfilePablo A González, View ORCID ProfileKatia Abarca, Alexis M Kalergis, View ORCID ProfileSusan M Bueno

doi: https://doi.org/10.1101/2021.11.16.21266350

Bárbara M Schultz

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Bárbara M Schultz

Felipe Melo-González

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Felipe Melo-González

Luisa F Duarte

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Luisa F Duarte

Nicolás MS Gálvez

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nicolás MS Gálvez

Gaspar A Pacheco

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gaspar A Pacheco

Jorge A Soto

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jorge A Soto

Roslye V Berríos-Rojas

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Roslye V Berríos-Rojas

Liliana A González

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela Moreno-Tapia

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniela Moreno-Tapia

Daniela Rivera-Pérez

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniela Rivera-Pérez

Guillermo Hoppe-Elsholz

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Guillermo Hoppe-Elsholz

Carolina Iturriaga

3Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mariana Ríos

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Omar P Vallejos

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Omar P Vallejos

Marcela Urzua

3Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yaneisi Vázquez

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yaneisi Vázquez

María S Navarrete

4Departamento de Enfermedades Infecciosas del Adulto, División de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Álvaro Rojas

4Departamento de Enfermedades Infecciosas del Adulto, División de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela Weiskopf

5Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alessandro Sette

5Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA

6Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alessandro Sette

Gang Zeng

7Sinovac Biotech, Beijing, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Weining Meng

7Sinovac Biotech, Beijing, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

José V González-Aramundiz

8Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for José V González-Aramundiz

Pablo A González

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pablo A González

Katia Abarca

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

3Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Katia Abarca

Alexis M Kalergis

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

9Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: sbueno@bio.puc.cl

Susan M Bueno

1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Susan M Bueno
For correspondence: sbueno@bio.puc.cl

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted November 17, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, Nicolás MS Gálvez, Gaspar A Pacheco, Jorge A Soto, Roslye V Berríos-Rojas, Liliana A González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Guillermo Hoppe-Elsholz, Carolina Iturriaga, Mariana Ríos, Omar P Vallejos, Marcela Urzua, Yaneisi Vázquez, María S Navarrete, Álvaro Rojas, Daniela Weiskopf, Alessandro Sette, Gang Zeng, Weining Meng, CoronaVac03CL Study Group, José V González-Aramundiz, Pablo A González, Katia Abarca, Alexis M Kalergis, Susan M Bueno

medRxiv 2021.11.16.21266350; doi: https://doi.org/10.1101/2021.11.16.21266350

Share This Article: